Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Eli Lilly and Company LLY

Healthcare  —  Drug Manufacturers General
1,183.46 1.57 0.13% as of 25 Sep
Market cap
$1.11T
P/E
39.7×
S&P 500 Member Dividend Aristocrat Revenue Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Eli Lilly and Company (LLY) Book value per share

Eli Lilly and Company's book value per share at the end of fiscal 2025 was 29.6×, up 86.6% from 15.8× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 38.0×. Over the past ten years it has ranged from 2.9× (fiscal 2019) to 29.6× (fiscal 2025) — the current reading is the highest in ten years. Eli Lilly and Company ranks 2nd of 21 Drug Manufacturers General companies by book value per share.

Book value per share, annual

Annual

Period Book value per share Change
FY2025 29.6× 86.61%
FY2024 15.8× 31.31%
FY2023 12.1× 0.99%
FY2022 11.9× 18.38%
FY2021 10.1× 57.27%
FY2020 6.4× 121.39%
FY2019 2.9× (72.69%)
FY2018 10.6× (4.29%)
FY2017 11.1× (16.64%)
FY2016 13.3× (3.17%)

Quarterly

Period Book value per share Change
Jun 2026 38.0× 8.85%
Mar 2026 34.9× 17.94%
Dec 2025 29.6× 11.20%
Sep 2025 26.6× 30.13%
42 more quarters

Against its own ten years

Low 2.9× High 29.6×
Ten-year median 11.9×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
LLY Eli Lilly and Company 38.0×
JNJ Johnson & Johnson compare 35.3×
AZN AstraZeneca PLC compare 32.5×
NVS Novartis AG compare 22.0×
AMGN Amgen Inc. compare 21.6×
MRK Merck & Co., Inc. compare 17.0×
PFE Pfizer Inc. compare 15.0×
GILD Gilead Sciences, Inc. compare 9.4×
ABBV AbbVie Inc. compare −3.3×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on LLY